ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO0894

Metabolic Alkalosis in Hemodialysis Patients: Worse Outcomes?

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Ávila, Gonçalo, Dialverca-dialysis clinic, Forte da Casa, Portugal
  • Matias, Patrícia, Dialverca-dialysis clinic, Forte da Casa, Portugal
  • Laranjinha, Ivo Jos? Dias, Dialverca-dialysis clinic, Forte da Casa, Portugal
  • Gil, Célia, Dialverca-dialysis clinic, Forte da Casa, Portugal
  • Ferreira, Manuel A., Dialverca-dialysis clinic, Forte da Casa, Portugal
Background

The ideal serum bicarbonate levels in prevalent hemodialysis (HD) patients is still debatable. Metabolic alkalosis in these patients has been associated with increased morbimortality. The aim of this study was to evaluate the association between serum bicarbonate and nutritional and cardiovascular risk markers, hospitalizations and mortality.

Methods

This was a single-center, retrospective study, of a cohort of 158 in-center HD patients, with a duration of 24 months. Serum bicarbonate levels were evaluated predialysis every 3 months. Body Composition Monitor was used to assess nutritional and hydration status. Electrocardiogram and echocardiogram data were obtained to calculate the QTc interval and the left ventricular mass index, respectively. Vascular calcifications were assessed using the Adragão score (SVCS).

Results

Mean age of the population was 69.8±12.6, 73% were male and 45% had diabetes. Median HD vintage was 59 months (IQR: 65 months). Mean serum bicarbonate was 23,5±1,57 mEq/L. There was as inverse association between serum bicarbonate and body mass index (r=-0.22, p=0.006), lean tissue index (r=-0.35, p<0.001), hemoglobin (r=-0.19, p=0.016), albumin (r=-0.30, p<0.001), phosphorus (r=-0.33, p<0.001) and nPCR (r=-0.41, p<0.001). Patients with greater SCVS (≥3) had higher mean serum bicarbonate (24.1±1.29 vs. 22.4±1.36 mEq/L, p<0.001). Higher serum bicarbonate was associated with an increased number of infection-related hospitalizations (p=0.009) and mortality (p=0.024), as well as all-cause mortality (p=0.012). Kaplan-Meier analysis revealed a significantly higher all-cause mortality in patients with serum bicarbonate ≥ 24.5 mEq/L at 24 months. The Cox regression analysis showed that serum bicarbonate was a predictor of all-cause mortality (p=0.004) in a model adjusted for age, dialysis vintage and the presence of diabetes.

Conclusion

In this population, higher serum bicarbonate was associated with a worse nutritional status and a higher cardiovascular risk, assessed by Adragão score. There was an association with an increased number of infection-related hospitalizations and mortality, as well as higher all-cause mortality. Serum bicarbonate levels ≥24.5 mEq/L were associated with lower survival at 24 months. Prospective studies are needed to determine the ideal serum bicarbonate levels in HD patients.